1 x 535.5g Sealed Tub by USP Labs in Apple
8-1-1 BCAA Ratio
Modern BCAA™ has been formulated with an 8-1-1 leucine-isoleucine-valine ratio…
In terms of the leucine, the reasoning here is that, from a strictly technical standpoint, the data displays that only leucine and those other amino acids structurally related to leucine are responsible for the increase in mTOR commonly associated with BCAA supplementation.
Results & Value
As you know, many people are doubling, tripling, even quadrupling their dosage of BCAAs with a 2:1:1 & 4:1:1 bias in order to achieve better results…
Given the fact that leucine is most likely the amino acid responsible for this effect, particularly in skeletal muscle, having a formula with an 8:1:1 ratio eliminates the need for such increased dosing.
Effectively creating an enormous value in addition to the other benefits.
3 Man Enter – 1 Man Leave
The other issue here is amino acid transport and metabolism. All three of the branched chain amino acids – leucine, isoleucine and valine – compete for the same transport systems, and as a result, the presence of high concentrations of the other two branch-chained amino acids may lower intracellular levels of leucine…
…Obviously NOT what you want…
This is further compounded by the fact that, once ingested, leucine first fulfills other structural roles unrelated to protein metabolism prior to activating mTOR signaling pathways…
The result is that BCAA products with a 2:1:1 or 4:1:1 bias may actually counteract the anabolic effects from the product, as these substrates are pitted against one another to compete for metabolism.
By increasing the “normal” ratio of leucine to the other two branched chain amino acids, we ensure two things:
1.Double & mega dosing are unnecessary, as we have already doubled the component that is primarily responsible for the protein turnover and synthesis increases we see with BCAAs.
2.Competitive metabolism between the amino acids will not lower leucine levels to the point that it is unable to regulate mTOR. Simply put, a 2:1:1 or 4:1:1 bias, while effective, is by no means optimal for mTOR signaling pathway activation, and an increase in protein synthesis associated with it.
There are instantized BCAA's – but they are incredibly expensive & made by using soy…
And I know you're tired of BCAA “floaties” and losing valuable product stuck to the side of the bottle…
That's why the BCAA's in USPlabs Modern BCAA utilize an advanced micronization process that produces an incredibly light & voluminous powder that mixes great! Plus, USPlabs Modern BCAA will keep you on your game at the gym or at work – no BCAA moustache or stained teeth to worry about…
Serving Size 2 Scoops
Servings Per Container 30
|Amount Per Serving||% DV|
|Proprietary Blend Modern BCAA||15000.00 mg||**|
|Micronized 8:1:1 BCAA Blend||**|
|Micronized L-Leucine L-Isoleucine L-Valine||**|
|L-Lysine HCl L-Taurine L-Alanine L-Glycine L-Alanyl-L-Glutamine (Sustamine)||**|
|Electrolyte Blend||703.00 mg||**|
|Sodium Citrate Potassium Chloride||**|
** Daily Value (DV) not established
We make no therapeutic use claims regarding the use of this product. Therapeutic is defined by the Australian Therapeautic Goods Administration (TGA) as:
· preventing, diagnosing, curing or alleviating a disease, ailment, defect or
· injury in persons or animals; or influencing, inhibiting or modifying a physiological process in persons or animals; or
· testing the susceptibility of persons or animals to a disease or ailment; or
· influencing, controlling or preventing conception in persons; or
· testing for pregnancy in persons; or
· the replacement or modification of parts of the anatomy in persons or animals